Table of Contents
Global Secondary Progressive Multiple Sclerosis Drug Market Research Report 2021
1 Secondary Progressive Multiple Sclerosis Drug Market Overview
1.1 Product Overview and Scope of Secondary Progressive Multiple Sclerosis Drug
1.2 Secondary Progressive Multiple Sclerosis Drug Segment by Type (Product Category)
1.2.1 Global Secondary Progressive Multiple Sclerosis Drug Production and CAGR (%) Comparison by Type (Product Category)(2016 - 2027)
1.2.2 Global Secondary Progressive Multiple Sclerosis Drug Production Market Share by Type (Product Category) in 2017
1.2.3 Inebilizumab
1.2.4 GLX - 1112
1.2.5 DC - TAB
1.2.6 Etomoxir
1.2.7 IB - MS
1.2.8 Others
1.3 Global Secondary Progressive Multiple Sclerosis Drug Segment by Application
1.3.1 Secondary Progressive Multiple Sclerosis Drug Consumption (Sales) Comparison by Application (2016 - 2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Secondary Progressive Multiple Sclerosis Drug Market by Region (2016 - 2027)
1.4.1 Global Secondary Progressive Multiple Sclerosis Drug Market Size (Value) and CAGR (%) Comparison by Region (2016 - 2027)
1.4.2 North America Status and Prospect (2016 - 2027)
1.4.3 Europe Status and Prospect (2016 - 2027)
1.4.4 China Status and Prospect (2016 - 2027)
1.4.5 Japan Status and Prospect (2016 - 2027)
1.4.6 Southeast Asia Status and Prospect (2016 - 2027)
1.4.7 India Status and Prospect (2016 - 2027)
1.5 Global Market Size (Value) of Secondary Progressive Multiple Sclerosis Drug (2016 - 2027)
1.5.1 Global Secondary Progressive Multiple Sclerosis Drug Revenue Status and Outlook (2016 - 2027)
1.5.2 Global Secondary Progressive Multiple Sclerosis Drug Capacity, Production Status and Outlook (2016 - 2027)
2 Global Secondary Progressive Multiple Sclerosis Drug Market Competition by Manufacturers
2.1 Global Secondary Progressive Multiple Sclerosis Drug Capacity, Production and Share by Manufacturers (2016 - 2021)
2.1.1 Global Secondary Progressive Multiple Sclerosis Drug Capacity and Share by Manufacturers (2016 - 2021)
2.1.2 Global Secondary Progressive Multiple Sclerosis Drug Production and Share by Manufacturers (2016 - 2021)
2.2 Global Secondary Progressive Multiple Sclerosis Drug Revenue and Share by Manufacturers (2016 - 2021)
2.3 Global Secondary Progressive Multiple Sclerosis Drug Average Price by Manufacturers (2016 - 2021)
2.4 Manufacturers Secondary Progressive Multiple Sclerosis Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Secondary Progressive Multiple Sclerosis Drug Market Competitive Situation and Trends
2.5.1 Secondary Progressive Multiple Sclerosis Drug Market Concentration Rate
2.5.2 Secondary Progressive Multiple Sclerosis Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Secondary Progressive Multiple Sclerosis Drug Capacity, Production, Revenue (Value) by Region (2016 - 2021)
3.1 Global Secondary Progressive Multiple Sclerosis Drug Capacity and Market Share by Region (2016 - 2021)
3.2 Global Secondary Progressive Multiple Sclerosis Drug Production and Market Share by Region (2016 - 2021)
3.3 Global Secondary Progressive Multiple Sclerosis Drug Revenue (Value) and Market Share by Region (2016 - 2021)
3.4 Global Secondary Progressive Multiple Sclerosis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.5 North America Secondary Progressive Multiple Sclerosis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.6 Europe Secondary Progressive Multiple Sclerosis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.7 China Secondary Progressive Multiple Sclerosis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.8 Japan Secondary Progressive Multiple Sclerosis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.9 Southeast Asia Secondary Progressive Multiple Sclerosis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.10 India Secondary Progressive Multiple Sclerosis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
4 Global Secondary Progressive Multiple Sclerosis Drug Supply (Production), Consumption, Export, Import by Region (2016 - 2021)
4.1 Global Secondary Progressive Multiple Sclerosis Drug Consumption by Region (2016 - 2021)
4.2 North America Secondary Progressive Multiple Sclerosis Drug Production, Consumption, Export, Import (2016 - 2021)
4.3 Europe Secondary Progressive Multiple Sclerosis Drug Production, Consumption, Export, Import (2016 - 2021)
4.4 China Secondary Progressive Multiple Sclerosis Drug Production, Consumption, Export, Import (2016 - 2021)
4.5 Japan Secondary Progressive Multiple Sclerosis Drug Production, Consumption, Export, Import (2016 - 2021)
4.6 Southeast Asia Secondary Progressive Multiple Sclerosis Drug Production, Consumption, Export, Import (2016 - 2021)
4.7 India Secondary Progressive Multiple Sclerosis Drug Production, Consumption, Export, Import (2016 - 2021)
5 Global Secondary Progressive Multiple Sclerosis Drug Production, Revenue (Value), Price Trend by Type
5.1 Global Secondary Progressive Multiple Sclerosis Drug Production and Market Share by Type (2016 - 2021)
5.2 Global Secondary Progressive Multiple Sclerosis Drug Revenue and Market Share by Type (2016 - 2021)
5.3 Global Secondary Progressive Multiple Sclerosis Drug Price by Type (2016 - 2021)
5.4 Global Secondary Progressive Multiple Sclerosis Drug Production Growth by Type (2016 - 2021)
6 Global Secondary Progressive Multiple Sclerosis Drug Market Analysis by Application
6.1 Global Secondary Progressive Multiple Sclerosis Drug Consumption and Market Share by Application (2016 - 2021)
6.2 Global Secondary Progressive Multiple Sclerosis Drug Consumption Growth Rate by Application (2016 - 2021)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Secondary Progressive Multiple Sclerosis Drug Manufacturers Profiles/Analysis
7.1 AB Science SA
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Secondary Progressive Multiple Sclerosis Drug Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 AB Science SA Secondary Progressive Multiple Sclerosis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.1.4 Main Business/Business Overview
7.2 Actelion Ltd
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Secondary Progressive Multiple Sclerosis Drug Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Actelion Ltd Secondary Progressive Multiple Sclerosis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.2.4 Main Business/Business Overview
7.3 Biogen, Inc.
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Secondary Progressive Multiple Sclerosis Drug Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Biogen, Inc. Secondary Progressive Multiple Sclerosis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.3.4 Main Business/Business Overview
7.4 F. Hoffmann - La Roche Ltd.
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Secondary Progressive Multiple Sclerosis Drug Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 F. Hoffmann - La Roche Ltd. Secondary Progressive Multiple Sclerosis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.4.4 Main Business/Business Overview
7.5 Genzyme Corporation
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Secondary Progressive Multiple Sclerosis Drug Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Genzyme Corporation Secondary Progressive Multiple Sclerosis Drug Capacity, Production, Revenue, Price and Gross Margin (2015 - 2021)
7.5.4 Main Business/Business Overview
7.6 Glialogix, Inc.
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Secondary Progressive Multiple Sclerosis Drug Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Glialogix, Inc. Secondary Progressive Multiple Sclerosis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.6.4 Main Business/Business Overview
7.7 Immune Response BioPharma, Inc.
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Secondary Progressive Multiple Sclerosis Drug Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Immune Response BioPharma, Inc. Secondary Progressive Multiple Sclerosis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.7.4 Main Business/Business Overview
7.8 Innate Immunotherapeutics Ltd
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Secondary Progressive Multiple Sclerosis Drug Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Innate Immunotherapeutics Ltd Secondary Progressive Multiple Sclerosis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.8.4 Main Business/Business Overview
7.9 Kyorin Pharmaceutical Co., Ltd.
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Secondary Progressive Multiple Sclerosis Drug Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Kyorin Pharmaceutical Co., Ltd. Secondary Progressive Multiple Sclerosis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.9.4 Main Business/Business Overview
7.10 Mallinckrodt Plc
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Secondary Progressive Multiple Sclerosis Drug Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Mallinckrodt Plc Secondary Progressive Multiple Sclerosis Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2020)
7.10.4 Main Business/Business Overview
7.11 MedDay SA
7.12 MedImmune, LLC
7.13 Merck KGaA
7.14 Meta - IQ ApS
7.15 Novartis AG
7.16 Opexa Therapeutics, Inc.
7.17 Xenetic Biosciences (UK) Limited
8 Secondary Progressive Multiple Sclerosis Drug Manufacturing Cost Analysis
8.1 Secondary Progressive Multiple Sclerosis Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Secondary Progressive Multiple Sclerosis Drug
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Secondary Progressive Multiple Sclerosis Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Secondary Progressive Multiple Sclerosis Drug Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Secondary Progressive Multiple Sclerosis Drug Market Forecast (2021 - 2027)
12.1 Global Secondary Progressive Multiple Sclerosis Drug Capacity, Production, Revenue Forecast (2021 - 2027)
12.1.1 Global Secondary Progressive Multiple Sclerosis Drug Capacity, Production and Growth Rate Forecast (2021 - 2027)
12.1.2 Global Secondary Progressive Multiple Sclerosis Drug Revenue and Growth Rate Forecast (2021 - 2027)
12.1.3 Global Secondary Progressive Multiple Sclerosis Drug Price and Trend Forecast (2021 - 2027)
12.2 Global Secondary Progressive Multiple Sclerosis Drug Production, Consumption , Import and Export Forecast by Region (2021 - 2027)
12.2.1 North America Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.2.2 Europe Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.2.3 China Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.2.4 Japan Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.2.5 Southeast Asia Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.2.6 India Secondary Progressive Multiple Sclerosis Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.3 Global Secondary Progressive Multiple Sclerosis Drug Production, Revenue and Price Forecast by Type (2021 - 2027)
12.4 Global Secondary Progressive Multiple Sclerosis Drug Consumption Forecast by Application (2021 - 2027)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Secondary Progressive Multiple Sclerosis Drug
Figure Global Secondary Progressive Multiple Sclerosis Drug Production () and CAGR (%) Comparison by Types (Product Category) (2016 - 2027)
Figure Global Secondary Progressive Multiple Sclerosis Drug Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Inebilizumab
Table Major Manufacturers of Inebilizumab
Figure Product Picture of GLX - 1112
Table Major Manufacturers of GLX - 1112
Figure Product Picture of DC - TAB
Table Major Manufacturers of DC - TAB
Figure Product Picture of Etomoxir
Table Major Manufacturers of Etomoxir
Figure Product Picture of IB - MS
Table Major Manufacturers of IB - MS
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Secondary Progressive Multiple Sclerosis Drug Consumption (K Pcs) by Applications (2016 - 2027)
Figure Global Secondary Progressive Multiple Sclerosis Drug Consumption Market Share by Applications in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Secondary Progressive Multiple Sclerosis Drug Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2016 - 2027)
Figure North America Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Europe Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure China Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Japan Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Southeast Asia Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure India Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Global Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) Status and Outlook (2016 - 2027)
Figure Global Secondary Progressive Multiple Sclerosis Drug Capacity, Production (K Pcs) Status and Outlook (2016 - 2027)
Figure Global Secondary Progressive Multiple Sclerosis Drug Major Players Product Capacity (K Pcs) (2016 - 2021)
Table Global Secondary Progressive Multiple Sclerosis Drug Capacity (K Pcs) of Key Manufacturers (2016 - 2021)
Table Global Secondary Progressive Multiple Sclerosis Drug Capacity Market Share of Key Manufacturers (2016 - 2021)
Figure Global Secondary Progressive Multiple Sclerosis Drug Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Secondary Progressive Multiple Sclerosis Drug Capacity (K Pcs) of Key Manufacturers in 2021
Figure Global Secondary Progressive Multiple Sclerosis Drug Major Players Product Production (K Pcs) (2016 - 2021)
Table Global Secondary Progressive Multiple Sclerosis Drug Production (K Pcs) of Key Manufacturers (2016 - 2021)
Table Global Secondary Progressive Multiple Sclerosis Drug Production Share by Manufacturers (2016 - 2021)
Figure 2017 Secondary Progressive Multiple Sclerosis Drug Production Share by Manufacturers
Figure 2017 Secondary Progressive Multiple Sclerosis Drug Production Share by Manufacturers
Figure Global Secondary Progressive Multiple Sclerosis Drug Major Players Product Revenue (Million USD) (2016 - 2021)
Table Global Secondary Progressive Multiple Sclerosis Drug Revenue (Million USD) by Manufacturers (2016 - 2021)
Table Global Secondary Progressive Multiple Sclerosis Drug Revenue Share by Manufacturers (2016 - 2021)
Table 2017 Global Secondary Progressive Multiple Sclerosis Drug Revenue Share by Manufacturers
Table 2021 Global Secondary Progressive Multiple Sclerosis Drug Revenue Share by Manufacturers
Table Global Market Secondary Progressive Multiple Sclerosis Drug Average Price (USD/Pcs) of Key Manufacturers (2016 - 2021)
Figure Global Market Secondary Progressive Multiple Sclerosis Drug Average Price (USD/Pcs) of Key Manufacturers in 2017
Table Manufacturers Secondary Progressive Multiple Sclerosis Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Secondary Progressive Multiple Sclerosis Drug Product Category
Figure Secondary Progressive Multiple Sclerosis Drug Market Share of Top 3 Manufacturers
Figure Secondary Progressive Multiple Sclerosis Drug Market Share of Top 5 Manufacturers
Table Global Secondary Progressive Multiple Sclerosis Drug Capacity (K Pcs) by Region (2016 - 2021)
Figure Global Secondary Progressive Multiple Sclerosis Drug Capacity Market Share by Region (2016 - 2021)
Figure Global Secondary Progressive Multiple Sclerosis Drug Capacity Market Share by Region (2016 - 2021)
Figure 2017 Global Secondary Progressive Multiple Sclerosis Drug Capacity Market Share by Region
Table Global Secondary Progressive Multiple
